S J Knechtle
Overview
Explore the profile of S J Knechtle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
2079
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manook M, Kwun J, Burghuber C, Samy K, Mulvihill M, Yoon J, et al.
Am J Transplant
. 2017 Feb;
17(8):2055-2064.
PMID: 28226413
Early activation of coagulation is an important factor in the initiation of innate immunity, as characterized by thrombotic microangiopathy (TMA). In transplantation, systemic anticoagulation is difficult due to bleeding. A...
2.
Barbas A, Knechtle S
Am J Transplant
. 2016 Jul;
16(11):3075-3076.
PMID: 27402131
No abstract available.
3.
Knechtle S, Fairchild R
Am J Transplant
. 2016 Jan;
16(7):1949-50.
PMID: 26792650
No abstract available.
4.
Burghuber C, Kwun J, Page E, Manook M, Gibby A, Leopardi F, et al.
Am J Transplant
. 2015 Dec;
16(6):1726-38.
PMID: 26705099
We have established a model of sensitization in nonhuman primates and tested two immunosuppressive regimens. Animals underwent fully mismatched skin transplantation, and donor-specific antibody (DSA) response was monitored by flow...
5.
Halazun K, Mathur A, Rana A, Massie A, Mohan S, Patzer R, et al.
Am J Transplant
. 2015 Nov;
16(1):137-42.
PMID: 26561981
Allocation policies for liver transplantation underwent significant changes in June 2013 with the introduction of Share 35. We aimed to examine the effect of Share 35 on regional variation in...
6.
Knechtle S, Sudan D
Am J Transplant
. 2015 Oct;
15(11):2791-2.
PMID: 26484836
No abstract available.
7.
Burghuber C, Roberts T, Knechtle S
Transplant Rev (Orlando)
. 2014 Dec;
29(1):16-22.
PMID: 25510576
The transplanted liver appears resistant to antibody-mediated injury compared to other transplanted organs such as kidney or heart. However, a growing number of reports suggest that alloantibody to the liver...
8.
Knechtle S, Adams A
Am J Transplant
. 2014 Jul;
14(8):1717-8.
PMID: 25041120
The results of the multicenter belatacept liver transplant trial disappoint with respect to safety and efficacy, and new approaches will be required before this agent plays a role in liver...
9.
OLeary J, Demetris A, Friedman L, Gebel H, Halloran P, Kirk A, et al.
Am J Transplant
. 2014 Mar;
14(4):779-87.
PMID: 24580828
The impact of donor-specific HLA alloantibodies (DSA) on short- and long-term liver transplant outcome is not clearly defined. While it is clear that not all levels of allosensitization produce overt...
10.
Kim E, Kwun J, Gibby A, Hong J, Farris 3rd A, Iwakoshi N, et al.
Am J Transplant
. 2013 Dec;
14(1):59-69.
PMID: 24354871
De novo donor-specific antibody (DSA) after organ transplantation promotes antibody-mediated rejection (AMR) and causes late graft loss. Previously, we demonstrated that depletion using anti-CD3 immunotoxin combined with tacrolimus and alefacept...